GAB2 and metabolic dysfunction-associated steatotic liver disease: Our previous research indicates that deletion of Gab2 in mice resists lipid accumulation in hepatocytes and hepatic steatosis induced by high-fat diet (HFD) by integrating multiple signal pathways, suggesting that Gab2 may be a potential target for preventing and treating fat accumulation diseases, including NAFLD and obesity31.